AKESF 株価推移チャート
AKESF 株価予測
Akeso, Inc.
$0
0%
$0
終値： Sep 02, 16:00:00 GMT-4
$0
0%
$0
アフターマーケット：Sep 02, 19:59:43 GMT-4
戻る
Akeso, Inc. (AKESF) 株価予測
主要データ
前終値
--
始値
--
当日レンジ
-
52週レンジ
-
取引高
--
平均取引高
1.5K
配当利回り
--
1株当たり利益(TTM)
-0.16
時価総額
--
AKESO INC.とは何ですか？
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company employs 3,761 full-time employees The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.
